The a2 Milk Company has met its lower end of guidance for double-digit revenue and earnings growth, but warns the key China market will be more challenging this year with China’s birth rate at a record low.
The infant formula producer, listed on the ASX and in New Zealand, also flagged prices will remain under pressure due to an increase in competition, excess manufacturing capacity and challenging macroeconomic conditions in the world’s biggest formula market valued at about $28 billion.